|
Gritstone Bio Inc (NASDAQ: GRTS) |
|
Gritstone Bio Inc
GRTS's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Gritstone Bio Inc 's sales fell
by -52.89 % in the second quarter of 2024 from the same quarter a year ago.
Ranking at No. 3134
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 12.11 %
Gritstone Bio Inc net loss decreased from $-35 millions, to $-23 millions in second quarter of 2024,
• More on GRTS's Growth
|
|
Gritstone Bio Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.6 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.32.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.18.
• More on GRTS's Valuation
|
|
|
|
|
Gritstone Bio Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.6 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.32.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.18.
Gritstone Bio Inc Price to Book Ratio is at 0.21 lower than Industry Avg. of 1871.42. and higher than S&P 500 Avg. of 0.01
• More on GRTS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com